These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19057310)

  • 1. Genomics of human glioblastoma multiforme: a glimpse of the future.
    Komotar RJ; Syed ON; Bruce JN; Connolly ES; Dunn IF; Friedlander RM
    Neurosurgery; 2008 Dec; 63(6):15. PubMed ID: 19057310
    [No Abstract]   [Full Text] [Related]  

  • 2. An integrated genomic analysis of human glioblastoma multiforme.
    Parsons DW; Jones S; Zhang X; Lin JC; Leary RJ; Angenendt P; Mankoo P; Carter H; Siu IM; Gallia GL; Olivi A; McLendon R; Rasheed BA; Keir S; Nikolskaya T; Nikolsky Y; Busam DA; Tekleab H; Diaz LA; Hartigan J; Smith DR; Strausberg RL; Marie SK; Shinjo SM; Yan H; Riggins GJ; Bigner DD; Karchin R; Papadopoulos N; Parmigiani G; Vogelstein B; Velculescu VE; Kinzler KW
    Science; 2008 Sep; 321(5897):1807-12. PubMed ID: 18772396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer genetics. A detailed genetic portrait of the deadliest human cancers.
    Kaiser J
    Science; 2008 Sep; 321(5894):1280-1. PubMed ID: 18772403
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.
    de Tayrac M; Etcheverry A; Aubry M; Saïkali S; Hamlat A; Quillien V; Le Treut A; Galibert MD; Mosser J
    Genes Chromosomes Cancer; 2009 Jan; 48(1):55-68. PubMed ID: 18828157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changes.
    Lo KC; Rossi MR; LaDuca J; Hicks DG; Turpaz Y; Hawthorn L; Cowell JK
    Genes Chromosomes Cancer; 2007 Oct; 46(10):875-94. PubMed ID: 17620294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA copy number variation and gene expression analyses reveal the implication of specific oncogenes and genes in GBM.
    Margareto J; Leis O; Larrarte E; Pomposo IC; Garibi JM; Lafuente JV
    Cancer Invest; 2009 Jun; 27(5):541-8. PubMed ID: 19219654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional changes in U343 MG-a glioblastoma cell line exposed to ionizing radiation.
    Bassi C; Mello SS; Cardoso RS; Godoy PD; Fachin AL; Junta CM; Sandrin-Garcia P; Carlotti CG; Falcão RP; Donadi EA; Passos GA; Sakamoto-Hojo ET
    Hum Exp Toxicol; 2008 Dec; 27(12):919-29. PubMed ID: 19273547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated high-resolution genome-wide analysis of gene dosage and gene expression in human brain tumors.
    Juric D; Bredel C; Sikic BI; Bredel M
    Methods Mol Biol; 2007; 377():187-202. PubMed ID: 17634618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.
    Jesionek-Kupnicka D; Kulczycka D; Rieske P; Szybka M; Jabłońska J; Potemski P; Kolasa P; Liberski PP; Kordek R
    Pol J Pathol; 2007; 58(2):79-85. PubMed ID: 17715673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.
    Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y
    Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IDH gene mutation in brain tumors].
    Sonoda Y; Tominaga T
    No Shinkei Geka; 2012 Apr; 40(4):297-306. PubMed ID: 22466228
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme.
    Khan I; Waqas M; Shamim MS
    J Pak Med Assoc; 2017 May; 67(5):816-817. PubMed ID: 28507382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An eQTL analysis of the human glioblastoma multiforme genome.
    Shpak M; Hall AW; Goldberg MM; Derryberry DZ; Ni Y; Iyer VR; Cowperthwaite MC
    Genomics; 2014 Apr; 103(4):252-63. PubMed ID: 24607568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.
    Ernst A; Hofmann S; Ahmadi R; Becker N; Korshunov A; Engel F; Hartmann C; Felsberg J; Sabel M; Peterziel H; Durchdewald M; Hess J; Barbus S; Campos B; Starzinski-Powitz A; Unterberg A; Reifenberger G; Lichter P; Herold-Mende C; Radlwimmer B
    Clin Cancer Res; 2009 Nov; 15(21):6541-50. PubMed ID: 19861460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
    Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J
    Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
    Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer. Puzzling patterns of predisposition.
    Pollard PJ; Ratcliffe PJ
    Science; 2009 Apr; 324(5924):192-4. PubMed ID: 19359573
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of the transcription level of the mitochondrial genome in human glioblastoma.
    Dmitrenko V; Shostak K; Boyko O; Khomenko O; Rozumenko V; Malisheva T; Shamayev M; Zozulya Y; Kavsan V
    Cancer Lett; 2005 Jan; 218(1):99-107. PubMed ID: 15639345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
    Nobusawa S; Watanabe T; Kleihues P; Ohgaki H
    Clin Cancer Res; 2009 Oct; 15(19):6002-7. PubMed ID: 19755387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.